Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04729387 |
|---|---|
| Brief Title: | Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected |
| First Submitted : | January 25, 2021 |
| First Submitted that Met QC Criteria : | January 25, 2021 |
| First Posted : | January 28, 2021 |
| Certification/Extension First Submitted : | April 17, 2024 |
| Certification/Extension First Posted : | February 28, 2024 |
| Last Update Submitted that Met QC Criteria : | April 19, 2024 |
| Last Update Posted : | April 22, 2024 |